The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Open accessAbstract
A molecular biology-based taxonomy has been proposed for pheochromocytoma and paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant prognostic and predictive biomarkers and stratified PPGLs into three main clusters. Each subgroup has a distinct molecular-biochemical-imaging signature. Concurrently, new methods for biochemical analysis, functional imaging, and medical therapies have also become available. The research community now strives to match the cluster biomarkers with the best intervention. The concept of precision medicine has been long awaited and holds great promise for improved care. Here, we review the current and future PPGL classifications, with a focus on hereditary syndromes. We discuss the current strengths and shortcomings of precision medicine and suggest a condensed manual for diagnosis and treatment of both adult and pediatric patients with PPGL. Finally, we consider the future direction of this field, with a particular focus on how advanced molecular characterization of PPGL can improve a patient's outcome, including cures and, ultimately, disease prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–236 of 236
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands
Hensen, E. F., van Duinen, N., Jansen, J. C., Corssmit, E. P. M., Tops, C., Romijn, J. A., Vriends, A. H. J. T., van der Mey, A., Cornelisse, C., Devilee, P., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01653.x · Cited by 63
Herold, C., Lewin, J. S., Wibmer, A. G., Thrall, J. H., Krestin, G. P., Dixon, A. K., Schoenberg, S. O., Geckle, R. J., Muellner, A., & Hricak, H. (2015) · Radiology · doi:10.1148/radiol.2015150709 · Cited by 61
Haissaguerre, M., Courel, M., Caron, P. J., Denost, S., Dubessy, C., Gosse, P., Appavoupoulle, V., Belleannée, G., Jullié, M., Montero‐Hadjadje, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1844 · Cited by 61
Genetic aspects of nonchromaffin paraganglioma
Fm, V. B., Cremers, C. W. R. J., van den Broek, P., Geerts, S. J., & Veldman, J. E. (1982) · Human Genetics · doi:10.1007/bf00569208 · Cited by 60
Taïeb, D., Yang, C., Delenne, B., Zhuang, Z., Barlier, A., Sebag, F. A., & Pacák, K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1217 · Cited by 59
Self-citationPenetrance and clinical consequences of a gross SDHB deletion in a large family
Solis, D. C., Burnichon, N., Timmers, H., Raygada, M. J., Kozupa, A., Merino, M. J., Makey, D., Adams, K. T., Vénisse, A., Gimenez‐Roqueplo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01157.x · Cited by 57
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Timmers, H. J. L. M., Brouwers, F. M., Hermus, A. R. M. M., Sweep, F. C. G. J., Verhofstad, A. A. J., Verbeek, A. L. M., Pacák, K., & Lenders, J. W. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0049 · Cited by 54
Developing biomarker-specific end points in lung cancer clinical trials
Neal, J. W., Gainor, J. F., & Shaw, A. T. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.222 · Cited by 51
Papathomas, T. G., Oudijk, L., Zwarthoff, E. C., Post, E., Duijkers, F. A. M., van Noesel, M. M., Hofland, L. J., Pollard, P. J., Maher, E. R., Restuccia, D. F., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0429 · Cited by 49
Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
Janssen, I., Chen, C. C., Zhuang, Z., Millo, C., Wolf, K. I., Ling, A. L., Lin, F. I., Adams, K. T., Herscovitch, P., Feelders, R. A., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187690 · Cited by 48
Self-citationClinical utility of chromogranin A in SDH x‐related paragangliomas
Zuber, S. M., WESLEY, R. A., Prodanov, T., Eisenhofer, G., Pacák, K., & Kantorovich, V. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12245 · Cited by 45
Crona, J., Nordling, M., Maharjan, R., Granberg, D. O., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086756 · Cited by 44
Self-citationUniversal Genetic Screening Uncovers a Novel Presentation of an SDHAF2 Mutation
Casey, R. T., Garrahy, A., Tuthill, A., O’Halloran, D., Joyce, C. M., Casey, M. B., O’Shea, P. M., & Bell, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4536 · Cited by 42
Backman, S., Maharjan, R., Falk-Delgado, A., Crona, J., Cupisti, K., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2017) · Scientific Reports · doi:10.1038/srep44943 · Cited by 42
Self-citationUtility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types
Kim, E., Wright, M. J., Sioson, L., Novos, T., Gill, A. J., Benn, D. E., White, C., Dwight, T., & Clifton-Bligh, R. J. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.12.006 · Cited by 41
Clinical Experience with Pheochromocytoma in a Single Centre Over 16 Years
Cotesta, D., Petramala, L., Serra, V., Pergolini, M., Crescenzi, E., Zinnamosca, L., Toma, G. D., Ciardi, A., Carbone, I., Massa, R., et al. (2009) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11530430-000000000-00000 · Cited by 37
Crona, J., Backman, S., Maharjan, R., Mayrhofer, M., Stalberg, P. L. H., Isaksson, A., Hellman, P., & Björklund, P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2854 · Cited by 36
Self-citationOxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
Her, Y. F., Nelson-Holte, M. H., & Maher, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127471 · Cited by 35
Closing the GAPP on predicting metastases
Eisenhofer, G., & Tischler, A. S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.41 · Cited by 31
Walls, G. V., Stevenson, M., Soukup, B. S., Lines, K. E., Grossman, A. B., SCHMID, H. A., & Thakker, R. V. (2016) · Endocrinology · doi:10.1210/en.2015-1965 · Cited by 30
Lips, C. J. M., Lentjes, E. G. W. M., Höppener, J. W. M., van der Luijt, R. B., & Moll, F. L. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-4-169 · Cited by 30
Obara, T., Kanbe, M., Okamoto, T., et al. (1995) · Surgery · doi:10.1016/s0039-6060(05)80118-7 · Cited by 29
Muth, A., Abel, F., Jansson, S. K. G., Nilsson, O., Ahlman, H., & Wängberg, B. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1430-6 · Cited by 29
Quality of life is decreased in patients with paragangliomas
van Hulsteijn, L. T., Louisse, A., Havekes, B., Kaptein, A. A., Jansen, J. C., Hes, F. J., Smit, J. W. A., & Corssmit, E. P. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0968 · Cited by 27
Oudard, S. M., Elaidi, R., Brizard, M., Rest, C. L., Caillet, V., Deveaux, S., Benoît, G., Corréas, J.-M., Benoudiba, F., David, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13301 · Cited by 27
Precision oncology: a strategy we were not ready to deploy
Fojo, T. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.01.005 · Cited by 24
SDHA mutated paragangliomas may be at high risk of metastasis
Tufton, N., Ghelani, R., Srirangalingam, U., Kumar, A., Drake, W. M., Iacovazzo, D., Skordilis, K., Berney, D. M., Al-Mrayat, M., Khoo, B. C. E., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0030 · Cited by 24
LONG-TERM EFFECT OF ADRENALECTOMY ON CARDIOVASCULAR REMODELING IN PATIENTS WITH PHEOCHROMOCYTOMA
Majtan, B., Zelinka, T., Rosa, J., Petrák, O., Krátká, Z., Štrauch, B., Tuka, V., Vranková, A., Michalský, D., Novák, K., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2422 · Cited by 23
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., Carpentier, P., Fleury-Goyon, M. C., & Gibold, C. (1991) · PubMed · Cited by 22
Rijken, J. A., Niemeijer, N. D., Corssmit, E. P. M., Jonker, M. A., Leemans, C. R., Menko, F. H., & Hensen, E. F. (2015) · Clinical Genetics · doi:10.1111/cge.12591 · Cited by 20
Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma
Sue, M., Martucci, V. L., Frey, F., Lenders, J. W. M., Timmers, H. J. L. M., Pęczkowska, M., Prejbisz, A., Brede, S., Bornstein, S. R., Arlt, W., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0756 · Cited by 18
Fliedner, S., Shankavaram, U., Marzouca, G., Elkahloun, A., Jochmanová, I., Daerr, R., Linehan, W., Timmers, H., Tischler, A., Papaspyrou, K., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.008 · Cited by 17
Self-citationSchovánek, J., Bullova, P., Tayem, Y. I., Giubellino, A., WESLEY, R. A., Lendvai, N. K., Nölting, S., Kopáček, J., Fryšák, Z., Pommier, Y. G., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1476 · Cited by 12
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours
Flynn, A., Dwight, T., Benn, D. E., Deb, S., Colebatch, A. J., Fox, S. B., Harris, J., Duncan, E. L., Robinson, B. G., Hogg, A., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4900 · Cited by 9
Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma
Bahougne, T., Impériale, A., Avérous, G., Chabrier, G., Burnichon, N., Gimenez‐Roqueplo, A., Dali‐Youcef, N., Libé, R., Baudin, É., Roy, C., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0431 · Cited by 3
Cited by
Fassnacht, M., Assie, G., Baudin, E., Eisenhofer, G., de la Fouchardiere, C., Haak, H. R., de Krijger, R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 436
Personalized Management of Pheochromocytoma and Paraganglioma
Nölting, S., Bechmann, N., Taieb, D., Beuschlein, F., Fassnacht, M., Kroiss, M., Eisenhofer, G., Grossman, A., & Pacak, K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab019 · Cited by 417
Self-citationLenders, J. W. M., Kerstens, M. N., Amar, L., Prejbisz, A., Robledo, M., Taieb, D., Pacak, K., Crona, J., Zelinka, T., Mannelli, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002438 · Cited by 413
Self-citationTaïeb, D., Hicks, R. J., Hindié, E., Guillet, B. A., Avram, A., Ghedini, P., Timmers, H. J., Scott, A. T., Elojeimy, S., Rubello, D., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04398-1 · Cited by 403
Self-citationApproach to the Patient With Adrenal Incidentaloma
Bancos, I., & Prete, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab512 · Cited by 201
Metadata
- Authors
- Crona, J., Taïeb, D., & Pacak, K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2017-08-04
- Volume
- 38
- Issue
- 6
- Pages
- 489-515
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2743282746
- Cited by
- 324
- References
- 236
- FWCI
- 27.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.